BLU

BELLUS Health (BLU) is the lead sponsor of 2 active clinical trials listed on ClinicalTrials.gov^[2], including 2 Phase 3^[1].

Trial NCT05599191^[3] evaluates BLU-5937 in Cough with a target enrollment of 825 participants. Trial NCT05600777^[4] evaluates BLU-5937 in Cough with a target enrollment of 975 participants.

No Form 4 insider filings for BLU were recorded at the SEC in the past 30 days^[5].